Unibest
← Back to patent-cliff list

BAY-85-8102

Tier C — Watch / trade

BAY-85-8102

Bayer
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:TSPO

Indications (approved):脑出血, Parkinson's disease, 神经炎, Idiopathic pulmonary fibrosis, 创伤后癫痫, Multiple sclerosis, 慢性疲劳综合征, Fibromyalgia

Regional status

US
Phase I
2019-02-03
EU
Phase II
2020-06-11
China
-
Japan
-

Synthetic routes & intermediates1 routes

Originator routes × 1Optimised (non-patent) × 0Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 6 · Total yield /
BAY-85-8102958233-09-5BAY-85-8102-0013672-47-7BAY-85-8102-0022315-36-8BAY-85-8102-003386298-14-2BAY-85-8102-004386298-19-7BAY-85-8102-005386297-97-8BAY-85-8102-006868072-17-7BAY-85-8102-007958233-17-5API · BAY-85-8102
CodeCAS No.Intermediate
BAY-85-8102958233-09-5N,N-diethyl-2-(2-(4-(2-(fluoro-18F)ethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide
BAY-85-8102-0013672-47-73-(4-methoxyphenyl)-3-oxopropanenitrile
BAY-85-8102-0022315-36-82-chloro-N,N-diethylacetamide
BAY-85-8102-003386298-14-23-cyano-N,N-diethyl-4-(4-methoxyphenyl)-4-oxobutanamide
BAY-85-8102-004386298-19-72-(5-amino-3-(4-methoxyphenyl)-1H-pyrazol-4-yl)-N,N-diethylacetamide
BAY-85-8102-005386297-97-8N,N-diethyl-2-(2-(4-methoxyphenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide
BAY-85-8102-006868072-17-7N,N-diethyl-2-(2-(4-hydroxyphenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide
BAY-85-8102-007958233-17-52-(4-(3-(2-(diethylamino)-2-oxoethyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-2-yl)phenoxy)ethyl 4-methylbenzenesulfonate

Frequently asked questions

What are the approved indications of BAY-85-8102?

Approved indications include: 脑出血, Parkinson's disease, 神经炎, Idiopathic pulmonary fibrosis, 创伤后癫痫, Multiple sclerosis, 慢性疲劳综合征, Fibromyalgia.

When does the BAY-85-8102 patent expire?

No public expiry year is available for BAY-85-8102 yet; this page updates once verified.

How many synthesis routes are recorded for BAY-85-8102?

1 synthesis routes are recorded; the shortest is 6 steps with / total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy BAY-85-8102 intermediates?

All intermediates in BAY-85-8102 routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for BAY-85-8102 intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-07